Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
21
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
HLS Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Aging Populations And Digital Patient Care Will Boost Vascepa Demand
Key Takeaways Expansion of the cardiovascular portfolio and operational efficiencies could significantly boost both margins and long-term earnings, surpassing current market expectations. Strategic financial discipline and demographic tailwinds position the company to pursue new growth avenues and sustain high revenue potential in its specialty portfolio.
View narrative
CA$9.51
FV
46.1% undervalued
intrinsic discount
5.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Worksport
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Electrification And Remote Lifestyles Will Expand Clean Markets
Key Takeaways Worksport's new high-margin products, operational efficiencies, and underappreciated government and corporate interest could accelerate both profitability and revenue growth far beyond market expectations. The company's alignment with rising clean energy and electrification trends, combined with its U.S. manufacturing base and IP strength, positions it for sustainable market leadership and earnings growth.
View narrative
US$12.50
FV
76.6% undervalued
intrinsic discount
109.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Milestone Scientific
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Aging Populations And Emerging Markets Will Drive Minimally Invasive Procedures
Key Takeaways Nationwide adoption of medical products, new leadership, and strategic partnerships position the company for rapid, high-margin growth and durable earnings expansion. Global infrastructure, proprietary technology, and competitive moats enable entry into new markets and verticals, sustaining outsized revenue and margin improvements.
View narrative
US$2.00
FV
70.1% undervalued
intrinsic discount
21.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Schrödinger
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Accelerating AI Adoption And Precision Medicine Will Empower Computational Breakthroughs
Key Takeaways Accelerating adoption of AI-powered software, cloud solutions, and regulatory engagement could drive substantial growth in both revenue and market reach. Strategic positioning in precision medicine and expanding collaborations position the company for sustained earnings growth and outsized industry influence.
View narrative
US$33.00
FV
41.3% undervalued
intrinsic discount
19.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
LivePerson
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Google Cloud And Databricks Will Fuel AI Customer Engagement
Key Takeaways Rapid generative AI adoption and digital transformation position LivePerson as a potential category leader, enabling outsized market share gains and structurally higher profitability. Strategic balance sheet improvements and specialized, secure AI offerings make LivePerson a trusted, de-risked partner for large enterprises, spurring long-term contract wins and recurring revenue growth.
View narrative
US$1.50
FV
28.7% undervalued
intrinsic discount
-11.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Vivos Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 2 Analysts
Rising Sleep Apnea Prevalence Will Accelerate Noninvasive Treatment Expansion
Key Takeaways Surging patient demand and rapid operational rollout support potential for significantly higher revenue, margin expansion, and accelerated positive cash flow beyond current expectations. Clinically validated solutions, experienced leadership, and streamlined workflows position the company for rapid, scalable growth and sustained, high-margin recurring revenue.
View narrative
US$6.20
FV
33.4% undervalued
intrinsic discount
19.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
ENNOSTAR
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Mini LED Manufacturing And Compound Semiconductors Will Transform High-Growth Markets
Key Takeaways Rapid mass production of advanced Mini/Micro LED and transparent displays positions ENNOSTAR for significant margin expansion and leadership in automotive applications. Strong cash reserves, vertical integration, and strategic alignment with high-growth markets enable aggressive investment and market share gains as global supply chains diversify.
View narrative
NT$49.50
FV
23.0% undervalued
intrinsic discount
5.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Inseego
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
5G Adoption And FWA Expansion Will Fuel IoT Growth
Key Takeaways Rapid new product adoption, expanded carrier partnerships, and channel wins in industrial IoT position Inseego for stronger market share, margin expansion, and diversified revenue streams. Accelerating SaaS and platform traction, alongside strategic leadership hires, could drive significant improvements in recurring revenue, operational efficiency, and profitability.
View narrative
US$13.50
FV
27.8% undervalued
intrinsic discount
9.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
i-80 Gold
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Global Inflation And Supply Scarcity Will Drive Nevada Gold Production
Key Takeaways Accelerated project development, higher-than-expected gold grades, and internalized processing could lead to significant outperformance in revenue, margins, and long-term earnings. Favorable gold market dynamics, strategic Nevada assets, and a robust funding strategy position the company for premium valuation and potential acquisition interest.
View narrative
CA$3.50
FV
73.1% undervalued
intrinsic discount
67.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies